Location History:
- Sykesville, MD (US) (2008 - 2010)
- Gaithersburg, PA (US) (2012)
- Gaithersburg, MD (US) (2014)
- Gettysburg, PA (US) (2010 - 2017)
- Smithland, KY (US) (2016 - 2024)
Company Filing History:
Years Active: 2008-2024
Title: Nadine Tuaillon: Innovator in HER2/neu-Specific Antibodies
Introduction
Nadine Tuaillon is a prominent inventor based in Gettysburg, PA (US). She has made significant contributions to the field of biotechnology, particularly in the development of HER2/neu-specific antibodies. With a total of 18 patents to her name, Tuaillon's work has the potential to impact the diagnosis and treatment of various diseases.
Latest Patents
One of Tuaillon's latest patents focuses on HER2/neu-specific antibodies and methods of using them. This invention relates to antibodies that specifically bind to HER2/neu, particularly chimeric 4D5 antibodies. These antibodies exhibit reduced glycosylation compared to known 4D5 antibodies. The invention also encompasses methods for utilizing these antibodies and compositions in the diagnosis, prognosis, and therapy of diseases such as cancer, autoimmune diseases, inflammatory disorders, and infectious diseases.
Career Highlights
Tuaillon is currently associated with Macrogenics, Inc., where she continues to advance her research and innovations. Her work has garnered attention in the scientific community, contributing to the understanding and treatment of complex diseases.
Collaborations
Some of her notable coworkers include Leslie Sydnor Johnson and Ezio Bonvini. Their collaborative efforts have further enhanced the research and development of innovative therapeutic solutions.
Conclusion
Nadine Tuaillon's contributions to the field of biotechnology, particularly through her patents on HER2/neu-specific antibodies, highlight her role as a leading inventor. Her work not only advances scientific knowledge but also holds promise for improving patient outcomes in various medical conditions.